From a Food-Borne Pathogen to a Groundbreaking Vaccine Biotechnology

NU School of Biotechnology has the pleasure of holding a seminar presented by Dr. Sherif Abouelhadid, a lead scientist in the field of public health and Head of Biological and Pharmacological Research Pillar at the Antimicrobial Research Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Dr. Sherif’s research focuses on glycobiology-based vaccine development, and he will give a talk entitled “From a food-borne pathogen to a groundbreaking vaccine biotechnology”. The talk will be held on Wednesday, December 13th, at 1 PM in UB1 Room 114.

Seminar Abstract:

Antibiotics which enabled the treatment of deadly bacterial infections, are now failing, ushering in vaccine development as a current global imperative. Conjugate vaccines have been demonstrated to be safe and efficacious in curbing infectious diseases, thus saving millions of lives worldwide. For decades, this type of vaccines was produced via a multi-step method that is expensive and laborious. The advent of bioconjugation heralds a new biotechnological era in vaccine development. However, current bioconjugation platforms have several shortcomings which hinder their wider availability. In this talk, Dr. Sherif will talk about his work on developing a novel glycoengineering tool that overcomes the limitations of bioconjugation methods. Additionally, he will discuss the immense potential of his group’s platform in developing vaccines that combat multidrug-resistant bacterial infection.

We cordially invite all students and staff members to attend this highly-anticipated session that will cover pioneering research in the field of vaccine biotechnology.